Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 246-257, February 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biedler, J. L.
Right arrow Articles by Hutchison, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biedler, J. L.
Right arrow Articles by Hutchison, D. J.

Cytogenetics of Mouse Leukemia L1210 I. Association of a Specific Chromosome with Dihydrofolate Reductase Activity in Amethopterin-treated Sublines1,2,

June L. Biedler3, Alberta M. Albrecht and Dorris J. Hutchison

( Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, and Sloan-Kettering Division, Graduate School of Medical Sciences, Cornell University Medical College, New York, New York)

Sublines initiated from small numbers of parental L1210 cells, where the chance of subtelocentric lacking variant cells being present was very small, were treated continually with amethopterin (Methotrexate) to which they became resistant. Chromosomal examinations and assays of dihydrofolate reductase activity were carried out at frequent intervals. In contrast to previous results the subtelocentric chromosomes did not disappear; rather, in 10 out of 18 sublines these bi-armed marker chromosomes were altered in some proportion of the population. Enzyme activity became elevated in all sublines, even where there was no detectable chromosomal alteration.

These data further indicated a relationship between the configuration of the subtelocentric chromosome characteristic of the L1210 cell and the enzyme dihydrofolate reductase. Mutagenic action of amethopterin was suggested.

1 A preliminary report of these studies was presented at a meeting of the American Association for Cancer Research at Toronto, Canada, on May 23, 1963.

2 This investigation was supported in part by grants CA 03192-07S1 and 1 SO FR 05226-01 from the National Institutes of Health, USPHS, and by grant T-107 from the American Cancer Society.

3 USPHS Research Career Development Awardee Grant 1-K3-CA-5275-01.

Received 7/31/64. Revised 10/22/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.